Cargando…
Broad blocking of MDR efflux pumps by acetylshikonin and acetoxyisovalerylshikonin to generate hypersensitive phenotype of malignant carcinoma cells
Cytotoxic activities of acetylshikonin and acetoxyisovalerylshikonin alone and in combination with chemotherapeutic agents against parental and drug resistant cell lines were determined using the MTT assay. Effects of Shikonin derivatives on BCRP, MDR1 and MRP transcript and protein levels were rela...
Autores principales: | Mirzaei, Seyed Abbas, Reiisi, Somayeh, Ghiasi Tabari, Parmida, Shekari, Abolfazl, Aliakbari, Fatemeh, Azadfallah, Elaheh, Elahian, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823906/ https://www.ncbi.nlm.nih.gov/pubmed/29472576 http://dx.doi.org/10.1038/s41598-018-21710-5 |
Ejemplares similares
-
Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell Lines
por: Kalalinia, Fatemeh, et al.
Publicado: (2014) -
Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review
por: Zhang, Zhiqin, et al.
Publicado: (2020) -
siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells
por: Heidari, Razieh, et al.
Publicado: (2021) -
Efficacy of Acetylshikonin in Preventing Obesity and Hepatic Steatosis in db/db Mice
por: Su, Mei-Ling, et al.
Publicado: (2016) -
Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013)